216 related articles for article (PubMed ID: 37489915)
1. Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
Johnston L; Dupuis E; Lam L; Poelman S
J Cutan Med Surg; 2023; 27(5):487-492. PubMed ID: 37489915
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Pain on Reduced Quality of Life in Patients with Hidradenitis Suppurativa: A Single-Center Retrospective Study.
Li Y; Speck P; Viera E; Siira M; Orenstein LAV
Dermatology; 2023; 239(6):1007-1012. PubMed ID: 37717562
[TBL] [Abstract][Full Text] [Related]
4. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting quality of life in patients with hidradenitis suppurativa.
Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
[TBL] [Abstract][Full Text] [Related]
6. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
[TBL] [Abstract][Full Text] [Related]
9. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
[TBL] [Abstract][Full Text] [Related]
10. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.
Vossen ARJV; Schoenmakers A; van Straalen KR; Prens EP; van der Zee HH
Am J Clin Dermatol; 2017 Oct; 18(5):687-695. PubMed ID: 28429245
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
Rivera-Díaz R; Pozo T; Alfageme F; Díaz Ley B; Osorio GF; Chico R; Vilarrasa E; Silvente C; Ciudad Blanco C; Romaní J; Martorell A; Fernández P; Romero Ferreiro C; Molina Leyva A
Actas Dermosifiliogr; 2023 Oct; 114(9):755-762. PubMed ID: 37331620
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study.
Koumaki D; Rovithi E; Solia Apokidou E; Papadakis M; Katoulis A; Evangelou G
Sci Rep; 2023 May; 13(1):7898. PubMed ID: 37193758
[TBL] [Abstract][Full Text] [Related]
14. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
15. Demographic and Clinical Features and Factors Affecting the Quality of Life of Patients With Hidradenitis Suppurativa: A Cross-sectional Study.
Erol Mart HM; Bostanci S; Caliskan Odabas D
Dermatol Surg; 2024 Jul; 50(7):630-635. PubMed ID: 38563434
[TBL] [Abstract][Full Text] [Related]
16. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG
J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338
[TBL] [Abstract][Full Text] [Related]
17. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
18. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
[TBL] [Abstract][Full Text] [Related]
19. Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
Orenstein LAV; Salame N; Siira MR; Urbanski M; Flowers NI; Echuri H; Garg A; McKenzie-Brown AM; Curseen KA; Patzer RE; Kavalieratos D; Chen SC
Br J Dermatol; 2023 Jan; 188(1):41-51. PubMed ID: 36689519
[TBL] [Abstract][Full Text] [Related]
20. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
Pavon Blanco A; Turner MA; Petrof G; Weinman J
Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
